The ERISA Industry Committee has submitted a comment letter to the Ohio House of Representatives Insurance Committee urging the panel to amend House Bill 291 to include access to all biosimilar products.
Join DSN and the AACP (American Association of Colleges of Pharmacy) for a free webinar: The Role of Pharmacy Mentorship & Growing Your Career...Monday, October 30th @ 6pm ET